Poor bioavailability, unstable therapeutics, limited tissue penetration, and off-target toxicity continue to constrain antiviral R&D. Liposome-based delivery systems offer researchers a flexible route to overcome these barriers.
Developing an effective therapeutic is only part of the challenge in modern drug discovery. Researchers must also ensure that an active molecule reaches the...
High antibody titers do not always reveal the full quality of vaccine-induced immunity. Explore how liposome-based adjuvants can shape functional responses—and why stability, characterization, and scale-up remain critical hurdles.
For developers of protein subunit and peptide vaccines, selecting a promising antigen is only the beginning. Purified antigens can produce limited immune...
Traditional neuroscience models often struggle to replicate human brain complexity, limiting predictive accuracy and creating challenges for drug discovery and neurological disease research. Advanced 3D neural spheroids and brain-on-a-chip technologies are emerging as valuable platforms to improve biological relevance, accelerate innovation, and support next-generation neuroscience studies....
Advanced neuroscience research increasingly relies on models that balance biological relevance, reproducibility, and scalability. Cell culture, cell line, and 3D models offer complementary strategies for studying neurological diseases.
Neurological disease research continues to face a fundamental challenge: the human nervous system is extraordinarily complex, while experimental models...
Despite rapid advances in regenerative medicine, iPSC generation remains a significant technical challenge due to challenges in efficiency, genomic integrity, and reproducibility. Discover how optimized viral and non-viral reprogramming strategies can help researchers overcome key barriers and accelerate stem cell research workflows.
Why iPSC Reprogramming Still Bottlenecks Stem Cell...
Stem cell research is reshaping disease modeling and drug discovery, but reproducibility, model relevance, and cell characterization remain major hurdles. Integrated stem cell platforms can help researchers close these gaps.
Why Better Cell Models Matter in Drug Discovery
Drug discovery continues to face a familiar problem: promising results in conventional preclinical models do not...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek